Axiom Investors’s Axcelis ACLS Stock Holding History

Axiom Investors’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-13,721	Closed	-$1.78M	–	139
2023 Q4	$1.78M	Sell	13,721 -3,663	-21%	-$505K	0.02%	124
2023 Q3	$2.83M	Sell	17,384 -1,022	-6%	-$180K	0.04%	88
2023 Q2	$3.37M	Buy	+18,406	New	+$2.65M	0.05%	85

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Axiom Investors's ACLS Position: Q1 2024 in Review

Axiom Investors sold out of Axcelis (ACLS) in Q1 2024, closing a stake of 13,721 shares — an estimated $1.78M sold.

Axiom Investors first reported a position in ACLS in Q2 2023 and held it in 3 quarters. The position peaked at $3.37M in Q2 2023. 386 funds tracked by Wall St. Rank hold ACLS as of Q1 2024.

Axiom Investors reported no remaining Axcelis position as of Q1 2024 after selling out during the quarter.
Axiom Investors sold 13,721 Axcelis shares in Q1 2024, an estimated $1.78M.
Axiom Investors first reported a position in Axcelis in Q2 2023 and held it in 3 quarters.
Axiom Investors's Axcelis position peaked at $3.37M in Q2 2023.
386 funds tracked by Wall St. Rank held Axcelis as of Q1 2024.

Based on Axiom Investors's 13F filing for Q1 2024, filed 13 May 2024.